374 related articles for article (PubMed ID: 26282158)
1. An Hourly Dose-Escalation Desensitization Protocol for Aspirin-Exacerbated Respiratory Disease.
Chen JR; Buchmiller BL; Khan DA
J Allergy Clin Immunol Pract; 2015; 3(6):926-31.e1. PubMed ID: 26282158
[TBL] [Abstract][Full Text] [Related]
2. Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.
Stevenson DD; Mehra PK; White AA; Gupta S; Woessner KM; Simon RA
J Allergy Clin Immunol; 2005 Oct; 116(4):755-60. PubMed ID: 16210047
[TBL] [Abstract][Full Text] [Related]
3. Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: A single-center study.
Waldram J; Walters K; Simon R; Woessner K; Waalen J; White A
J Allergy Clin Immunol; 2018 Jan; 141(1):250-256. PubMed ID: 28550988
[TBL] [Abstract][Full Text] [Related]
4. A 1-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory Disease.
DeGregorio GA; Singer J; Cahill KN; Laidlaw T
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1174-1180. PubMed ID: 30391549
[TBL] [Abstract][Full Text] [Related]
5. Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease.
Hope AP; Woessner KA; Simon RA; Stevenson DD
J Allergy Clin Immunol; 2009 Feb; 123(2):406-10. PubMed ID: 19056109
[TBL] [Abstract][Full Text] [Related]
6. Frequency and severity of reactions to a 325-mg aspirin dose during desensitization.
Schuler CF; Baldwin JL; Baptist AP
Ann Allergy Asthma Immunol; 2017 Mar; 118(3):333-338.e1. PubMed ID: 28065801
[TBL] [Abstract][Full Text] [Related]
7. [Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day].
Gosepath J; Schäfer D; Mann WJ
Laryngorhinootologie; 2002 Oct; 81(10):732-8. PubMed ID: 12397524
[TBL] [Abstract][Full Text] [Related]
8. [Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases].
Cambray-Gutiérrez JC; García-Ramírez UN; Del Rivero-Hernández LG; Lozano-Martínez SA; López-Pérez P; Chávez-García A
Rev Alerg Mex; 2016; 63(2):207-12. PubMed ID: 27174764
[TBL] [Abstract][Full Text] [Related]
9. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper.
Macy E; Bernstein JA; Castells MC; Gawchik SM; Lee TH; Settipane RA; Simon RA; Wald J; Woessner KM;
Ann Allergy Asthma Immunol; 2007 Feb; 98(2):172-4. PubMed ID: 17304886
[TBL] [Abstract][Full Text] [Related]
10. The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD).
Spies JW; Valera FC; Cordeiro DL; de Mendonça TN; Leite MG; Tamashiro E; Arruda LK; Anselmo-Lima WT
Braz J Otorhinolaryngol; 2016; 82(3):263-8. PubMed ID: 26601997
[TBL] [Abstract][Full Text] [Related]
11. An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease.
Shaker M; Lobb A; Jenkins P; O'Rourke D; Takemoto SK; Sheth S; Burroughs T; Dykewicz MS
J Allergy Clin Immunol; 2008 Jan; 121(1):81-7. PubMed ID: 17716716
[TBL] [Abstract][Full Text] [Related]
12. Performing Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease.
Waldram JD; Simon RA
Immunol Allergy Clin North Am; 2016 Nov; 36(4):693-703. PubMed ID: 27712764
[TBL] [Abstract][Full Text] [Related]
13. [Self-desensitization with aspirin in a patient with aspirin intolerance].
Rozsasi A; Keck T
Laryngorhinootologie; 2009 Aug; 88(8):540-1. PubMed ID: 19562656
[No Abstract] [Full Text] [Related]
14. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
White AA; Stevenson DD; Simon RA
Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
[TBL] [Abstract][Full Text] [Related]
15. Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD).
Simon RA; Dazy KM; Waldram JD
Curr Allergy Asthma Rep; 2015 Mar; 15(3):508. PubMed ID: 25663486
[TBL] [Abstract][Full Text] [Related]
16. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
Ledford DK; Wenzel SE; Lockey RF
J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
[TBL] [Abstract][Full Text] [Related]
17. Effect of misoprostol on patients with aspirin-exacerbated respiratory disease undergoing aspirin challenge and desensitization.
Walters KM; Simon RA; Woessner KM; Wineinger NE; White AA
Ann Allergy Asthma Immunol; 2017 Jul; 119(1):71-76. PubMed ID: 28668243
[TBL] [Abstract][Full Text] [Related]
18. Aspirin desensitization in patients with AERD.
Stevenson DD
Clin Rev Allergy Immunol; 2003 Apr; 24(2):159-68. PubMed ID: 12668896
[TBL] [Abstract][Full Text] [Related]
19. Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease.
Fruth K; Pogorzelski B; Schmidtmann I; Springer J; Fennan N; Fraessdorf N; Boessert A; Schaefer D; Gosepath J; Mann WJ
Allergy; 2013; 68(5):659-65. PubMed ID: 23464577
[TBL] [Abstract][Full Text] [Related]
20. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
Walters KM; Waldram JD; Woessner KM; White AA
Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]